Revolution Medicines, Inc.RVMD

Market cap

$14.7B

P/E ratio

	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024
Cash and cash equivalents	104	108	161	696	543
Marketable securities	336	469	484	1,157	1,746
Account receivable	-	6	5	1	-
Prepaid expenses and other current assets	7	7	11	25	38
Total current assets	454	590	660	1,879	2,328
Property and equipment, net	9	12	19	23	24
Operating lease right-of-use asset	27	60	55	77	118
Intangible assets, net	61	60	59	58	57
Goodwill	15	15	15	15	15
Restricted cash	1	2	2	3	4
Other noncurrent assets	0	1	3	7	14
Total assets	567	738	812	2,062	2,558
Accounts payable	13	14	21	62	54
Accrued expenses and other current liabilities	19	28	29	75	97
Operating lease liability, current	4	6	7	7	13
Total current liabilities	47	60	62	144	164
Deferred tax liability	7	7	7	3	2
Operating lease liability, noncurrent	29	60	57	81	123
Warrant liability	-	-	-	7	3
Other noncurrent liabilities	1	1	0	1	1
Total liabilities	93	135	127	236	293
Common Stock, Value, Issued	0	0	0	0	0
Additional paid-in capital	740	1,056	1,388	2,963	4,002
Accumulated other comprehensive income	0	-0	-2	1	1
Accumulated deficit	-266	-453	-701	-1,100	-1,700
Total stockholders' equity	475	603	685	1,826	2,265
Total liabilities and stockholders' equity	567	738	812	2,062	2,558